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Methicillin-resistant *Staphylococcus aureus* (MRSA) was first isolated in 1961 ([@B1]). MRSA rapidly became widespread in the hospital setting and remained contained there until the late 1990s, when isolates began infecting patients with no known risk factors for hospital-acquired MRSA (HA-MRSA) ([@B2]). This subset of MRSA isolates was termed community-acquired MRSA (CA-MRSA). The third group of isolates are acquired by contact with livestock species and are called livestock-associated MRSA (LA-MRSA). Specific lineages of *S. aureus* predominate within each subset, and these lineages are defined by their multilocus sequence type (ST). *S. aureus* lineages are defined by differing characteristics that allow them to possess distinct niches. The ST5 lineage, specifically, is a widespread and successful lineage of HA-MRSA ([@B3]). This is primarily attributed to the capacity of this lineage to acquire mobile genetic elements encoding virulence factors and antimicrobial resistance genes ([@B3]).

Here, we report the generation of 50 draft genome sequences from MRSA ST5 isolates obtained from the hospital at the University of California, Irvine ([@B4]). Isolates sequenced, listed in [Table 1](#tab1){ref-type="table"}, were from patients who had MRSA-related disease and no known livestock exposure. Minimal patient history was available, including source information, making HA- and CA-MRSA indistinguishable. The isolates were grown in trypticase soy broth (BD Biosciences, Sparks, MD), and the High Pure Template preparation kit (Roche Applied Science, Indianapolis, IN) was used to isolate total genomic DNA.

###### 

Assembled draft genome sequences obtained from this project

  Isolate name   Avg coverage   No. of contigs   GenBank accession no.
  -------------- -------------- ---------------- ------------------------------------------------------------------
  UCI 1          73.13          89               [LKYS00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKYS00000000)
  UCI 2          51.15          162              [LKYT00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKYT00000000)
  UCI 4          69.93          137              [LKYV00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKYV00000000)
  UCI 5          83.47          105              [LKYW00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKYW00000000)
  UCI 6          59.19          111              [LKYX00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKYX00000000)
  UCI 7          51.04          158              [LKYY00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKYY00000000)
  UCI 8          53.59          120              [LKYZ00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKYZ00000000)
  UCI 10         50.26          125              [LKZB00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZB00000000)
  UCI 12         61.68          167              [LKZD00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZD00000000)
  UCI 13         46.01          144              [LKZE00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZE00000000)
  UCI 14         43.15          183              [LKZF00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZF00000000)
  UCI 15         46.20          123              [LKZG00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZG00000000)
  UCI 16         83.09          117              [LKZH00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZH00000000)
  UCI 17         83.32          140              [LKZI00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZI00000000)
  UCI 18         55.44          205              [LKZJ00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZJ00000000)
  UCI 20         55.04          201              [LKZL00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZL00000000)
  UCI 22         59.19          148              [LKZN00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZN00000000)
  UCI 23         38.77          311              [LKZO00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZO00000000)
  UCI 25         80.63          125              [LKZQ00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZQ00000000)
  UCI 26         71.95          114              [LKZR00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZR00000000)
  UCI 28         48.98          145              [LKZT00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZT00000000)
  UCI 29         65.78          247              [LKZU00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZU00000000)
  UCI 30         66.07          148              [LKZV00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZV00000000)
  UCI 31         56.88          219              [LKZW00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZW00000000)
  UCI 32         43.65          269              [LKZX00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZX00000000)
  UCI 33         43.35          242              [LKZY00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZY00000000)
  UCI 34         49.12          224              [LKZZ00000000](http://www.ncbi.nlm.nih.gov/nuccore/LKZZ00000000)
  UCI 35         46.42          111              [LLAA00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAA00000000)
  UCI 36         46.00          246              [LLAB00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAB00000000)
  UCI 37         37.53          264              [LLAC00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAC00000000)
  UCI 38         53.12          227              [LLAD00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAD00000000)
  UCI 39         83.79          107              [LLAE00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAE00000000)
  UCI 40         44.79          171              [LLAF00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAF00000000)
  UCI 41         50.09          175              [LLAG00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAG00000000)
  UCI 42         54.66          160              [LLAH00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAH00000000)
  UCI 44         60.57          140              [LLAJ00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAJ00000000)
  UCI 47         65.17          191              [LLAM00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAM00000000)
  UCI 49         57.85          237              [LLAO00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAO00000000)
  UCI 50         50.05          174              [LLAP00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAP00000000)
  UCI 51         41.44          184              [LLAQ00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAQ00000000)
  UCI 53         69.80          97               [LLAS00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAS00000000)
  UCI 54         49.38          138              [LLAT00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAT00000000)
  UCI 55         80.91          156              [LLAU00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAU00000000)
  UCI 57         80.99          87               [LLAW00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAW00000000)
  UCI 58         79.17          112              [LLAX00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAX00000000)
  UCI 59         82.31          132              [LLAY00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAY00000000)
  UCI 60         49.91          231              [LLAZ00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLAZ00000000)
  UCI 61         66.52          178              [LLBA00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLBA00000000)
  UCI 62         61.44          131              [LLBB00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLBB00000000)
  UCI 63         54.37          96               [LLBC00000000](http://www.ncbi.nlm.nih.gov/nuccore/LLBC00000000)

Draft genome sequences were produced using the Illumina MiSeq platform. Indexed libraries were produced with the Nextera XT DNA sample preparation and index kit (Illumina, San Diego, CA). Sequencing employed the MiSeq v2 500 Cycle reagent kit (Illumina) and generated 2 × 250-bp paired-end reads.

Sequence reads were assembled into draft genomes using MIRA v4.0.2 (<http://mira-assembler.sourceforge.net/docs/DefinitiveGuideToMIRA.html>). The average coverage for each isolate is listed in [Table 1](#tab1){ref-type="table"}. For retention in the assembly, the contigs were required to be \>1,500 bp and have a coverage with at least two-thirds the average coverage of the genome. When repetitive elements were identified during assembly, the contig was required to be \>2,000 bp to be included in the assembly.

Accession number(s). {#s1}
--------------------

The assembled draft genome sequences obtained from this project were deposited into DDBJ/ENA/GenBank with the accession numbers listed in [Table 1](#tab1){ref-type="table"}.
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